Drug shows promising signs for postmenopausal women with osteoporosis

Postmenopausal women with osteoporosis who took romosozumab for a year experienced “rapid and large reductions” in risk of fracturing vertebrae.

Though vitamin D helps protect older adults from osteoporosis, doctors may be over-testing for vitamin deficiency.

The presence of the antibody rheumatoid factor (RF) in seemingly healthy men could have a negative effect on their bone density.

Women who have pregnancies less than a year apart may have a greater risk for osteoporosis.

Bone-health experts are making a new push to reduce rates of osteoporosis, with a particular focus on treating men.